Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in adults over 55 years old1 . This progressive eye disease primarily affects the macula, the central part of the retina responsible for sharp, detailed vision1 . Early detection of AMD is crucial to slow disease progression and preserve vision, making a thorough diagnostic process essential1 . This article outlines the comprehensive steps and tests involved in diagnosing macular degeneration.
Diagnostic Process Overview
The diagnosis of macular degeneration involves a combination of clinical evaluation, patient history, and specialized eye examinations. AMD is classified into two main types: dry (atrophic) and wet (neovascular) 1. Dry AMD accounts for approximately 85-90% of cases and progresses slowly with gradual vision loss, while wet AMD is less common but characterized by rapid progression and severe vision loss due to abnormal blood vessel growth beneath the retina1 .
Diagnosis begins with identifying hallmark signs such as drusen (yellow deposits under the retina), retinal pigment epithelium changes, geographic atrophy (advanced dry AMD), and choroidal neovascularization (wet AMD) through clinical examination and imaging1 . Imaging techniques like optical coherence tomography (OCT), fluorescein angiography (FAA), and fundus autofluorescence are critical for confirming the diagnosis and staging the disease1 . Functional tests such as the Amsler grid help detect central vision distortions indicative of AMD2 .
A positive diagnosis requires differentiating AMD from other retinal diseases, including hereditary macular dystrophies and drug-induced retinal toxicity, which can mimic AMD symptoms3 4. The diagnostic process integrates patient history, symptom assessment, and detailed eye examination findings to establish the presence and stage of AMD.
Patient History and Symptoms
A thorough medical history is essential to differentiate AMD from other causes of vision loss and to assess risk factors1 . Age over 55 is a major risk factor routinely evaluated during diagnosis1 . Since AMD has a genetic component, family history of vision problems is also considered3 . Patients are asked about their symptoms, including the onset and progression of vision changes, which guide diagnosis and management decisions1 .
Common symptoms of AMD include:
- Blurring or distortion of central vision, such as straight lines appearing wavy (metamorphopsia) 1.
- Central scotomas (blind spots) or dark areas in the central visual field1 .
- Difficulty recognizing faces or reading fine print1 .
- Problems with low-light vision and changes in color perception1 .
Early dry AMD is often asymptomatic but may be detected by identifying drusen during an eye exam1 . Wet AMD typically presents with rapid vision loss and central distortion due to abnormal blood vessel leakage1 .
Comprehensive Eye Examination
A comprehensive eye examination is necessary to detect AMD and evaluate the extent of vision loss1 . The exam includes several components:
- Visual acuity testing to measure clarity of vision at various distances1 .
- Peripheral vision assessment to rule out other ocular conditions1 .
- Ocular motility and pupil response evaluation to exclude neurological or ocular disorders1 .
- Tonometry to measure intraocular pressure and exclude glaucoma, which can coexist with AMD1 .
Based on initial findings, further diagnostic imaging or tests are ordered to confirm AMD and assess its severity1 .
Amsler Grid
The Amsler grid is a simple, widely used tool to detect central visual distortions characteristic of AMD2 . Patients focus on a central point on a grid of straight lines and report any areas where lines appear wavy, broken, blurry, or missing2 . This test is effective in identifying metamorphopsia and central scotomas, hallmark symptoms of AMD progression2 . Patients can also use the Amsler grid at home to monitor changes in their vision over time.
Slit Lamp Exam
Slit lamp biomicroscopy is essential for detecting early AMD signs before symptoms arise1 . After pupil dilation, the eye care provider uses a specialized microscope to examine the retina and macula in detail1 . This exam allows direct visualization of drusen deposits, retinal pigment epithelium alterations, and signs of geographic atrophy or neovascularization1 . The slit lamp exam helps differentiate dry and wet AMD based on clinical features.
Optical Coherence Tomography (OCT)
OCT is a noninvasive imaging technique that produces detailed cross-sectional images of the retina and macula1 . It identifies areas of thinning, thickening, or swelling caused by fluid accumulation from leaking blood vessels in wet AMD or atrophic changes in dry AMD1 . OCT is critical for confirming the presence of choroidal neovascularization and monitoring disease progression1 . It is commonly used alongside other imaging modalities to stage AMD accurately.
Fluorescein Angiography (FAA)
Fluorescein angiography involves injecting a fluorescent dye into a vein in the arm and capturing images as the dye circulates through the retinal blood vessels1 . This test detects leakage, hemorrhage, and abnormal blood vessel growth characteristic of wet AMD and polypoidal choroidal vasculopathy (PCV), an important differential diagnosis4 . FAA helps guide treatment decisions by revealing the extent and activity of neovascularization4 .
Disease Stages and Classification
“Faricimab will sometimes need to be administered frequently to keep the disease under control.”
— Carl Regillo, MD6
AMD is classified into dry (atrophic) and wet (neovascular) types, each with distinct stages and clinical features1 .
| Type | Stage | Key Features | Vision Impact |
|---|---|---|---|
| Dry AMD | Early | Small drusen deposits, no symptoms1 | Often asymptomatic |
| Dry AMD | Intermediate | Larger drusen, mild visual symptoms1 | Mild central vision blurring |
| Dry AMD | Advanced (Geographic Atrophy) | Localized macular cell loss, retinal pigment changes1 | Significant central vision loss |
| Wet AMD | Advanced | Choroidal neovascularization, fluid leakage, hemorrhage1 | Rapid, severe central vision loss |
| Sources: 1 | |||
Dry AMD progresses slowly through early, intermediate, and advanced stages, with gradual vision loss1 . Wet AMD is considered an advanced form due to its rapid progression and severe impact on vision1 . Central vision distortion, scotomas, and reduced color perception are clinical signs of disease progression1 .
💡 Did You Know?
Inflammatory, genetic, degenerative, and idiopathic diseases can also cause neovascularization but usually affect younger patients, making positive diagnosis of wet AMD critical using clinical history and imaging5 .
Evaluating Related Health Conditions
Differential diagnosis is important to exclude other causes of macular changes and vision loss. Conditions to consider include hereditary macular dystrophies and retinal toxicity from medications such as hydroxychloroquine, deferoxamine, and cisplatin3 . Polypoidal choroidal vasculopathy (PCV) mimics wet AMD clinically but requires different management4 .
Screening for coexisting ocular conditions like glaucoma is performed during the eye exam using tonometry1 . Systemic factors such as age, smoking history, diet, and family history are assessed as they influence AMD risk and progression1 .
“I think gene therapy treatments are the game changers that we really want to be able to offer our patients.”
— Adrienne Scott, MD6
Summary of Diagnosis Steps
The diagnosis of macular degeneration involves a systematic approach combining history, examination, and diagnostic testing:
- Obtain detailed patient history, including age, family history, symptom onset, and progression1 .
- Conduct comprehensive eye examination with visual acuity, pupil response, tonometry, and peripheral vision testing1 .
- Use the Amsler grid to detect central vision distortions2 .
- Perform slit lamp biomicroscopy after pupil dilation to visualize drusen, retinal pigment epithelium changes, and neovascularization1 .
- Employ imaging modalities such as OCT and fluorescein angiography to confirm diagnosis and stage AMD1 4.
- Differentiate AMD from other retinal diseases and drug toxicities through clinical and imaging findings3 4.
Early detection through this diagnostic process enables timely intervention to slow progression and preserve vision1 .
